Literature DB >> 12094562

Progressive external ophthalmoplegia and multiple mitochondrial DNA deletions.

Gert Van Goethem1, Jean-Jacques Martin, Christine Van Broeckhoven.   

Abstract

Progressive external ophthalmoplegia (PEO) with secondary accumulation of multiple deletions of mitochondrial DNA (mtDNA) clinically resembles disorders due to primary mutations of mtDNA but follows a Mendelian inheritance pattern. The disorder belongs to an interesting group of diseases in which both the nuclear and the mitochondrial genome are involved in the pathology. Both autosomal dominant (adPEO) and recessive (arPEO) variants of this disorder occur. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) patients may have multiple mtDNA deletions and/or depletion of mtDNA. Recent reports of mutations in Thymidine Phosphorylase in MNGIE, and of mutations in adenine nucleotide translocator (ANT1), Twinkle and mitochondrial DNA polymerase gamma (POLG) in adPEO, have lead to new insights in the pathogenesis of these disorders of mtDNA maintenance. We also identified POLG mutations in two families with arPEO, which underlines the crucial role of the mtDNA replication machinery for mtDNA maintenance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094562

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  11 in total

Review 1.  Insights into the mitochondrial signaling pathway: what lessons for chemotherapy?

Authors:  Catherine Brenner; Morgane Le Bras; Guido Kroemer
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

2.  Effect of the Y955C mutation on mitochondrial DNA polymerase nucleotide incorporation efficiency and fidelity.

Authors:  Patricia A Estep; Kenneth A Johnson
Journal:  Biochemistry       Date:  2011-07-05       Impact factor: 3.162

3.  Roles of Mitochondrial DNA Changes on Cancer Initiation and Progression.

Authors:  Masahiro Higuchi
Journal:  Cell Biol (Henderson, NV)       Date:  2012-10-25

4.  Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma.

Authors:  Geetha Achanta; Ryohei Sasaki; Li Feng; Jennifer S Carew; Weiqin Lu; Helene Pelicano; Michael J Keating; Peng Huang
Journal:  EMBO J       Date:  2005-09-15       Impact factor: 11.598

5.  POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype.

Authors:  Tuomas Komulainen; Reetta Hinttala; Mikko Kärppä; Leila Pajunen; Saara Finnilä; Hannu Tuominen; Heikki Rantala; Ilmo Hassinen; Kari Majamaa; Johanna Uusimaa
Journal:  BMC Neurol       Date:  2010-05-03       Impact factor: 2.474

Review 6.  Lacritin and other new proteins of the lacrimal functional unit.

Authors:  Robert L McKown; Ningning Wang; Ronald W Raab; Roy Karnati; Yinghui Zhang; Patricia B Williams; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2008-09-18       Impact factor: 3.467

7.  Abnormalities in glycogen metabolism in a patient with alpers' syndrome presenting with hypoglycemia.

Authors:  Mariella Simon; Richard C Chang; Deeksha S Bali; Lee-Jun Wong; Ying Peng; Jose E Abdenur
Journal:  JIMD Rep       Date:  2013-11-23

Review 8.  Cardiological manifestations of mitochondrial respiratory chain disorders.

Authors:  A Berardo; O Musumeci; A Toscano
Journal:  Acta Myol       Date:  2011-06

9.  TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells.

Authors:  Serena Altilia; Aurelia Santoro; Davide Malagoli; Catia Lanzarini; Josué Adolfo Ballesteros Álvarez; Gianluca Galazzo; Donald Carl Porter; Paolina Crocco; Giuseppina Rose; Giuseppe Passarino; Igor Boris Roninson; Claudio Franceschi; Stefano Salvioli
Journal:  Aging (Albany NY)       Date:  2012-01       Impact factor: 5.682

Review 10.  Mitochondrial DNA disease-molecular insights and potential routes to a cure.

Authors:  Oliver Russell; Doug Turnbull
Journal:  Exp Cell Res       Date:  2014-03-24       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.